Fundraising FoxCour Pharmaceuticals Development
Northbrook, US · Founded 2012 · Delaware corporation
Find your way into Cour Pharmaceuticals Development
439 people in our graph can introduce you to the Cour Pharmaceuticals Development team.
Sign up to see every warm intro you have to Cour Pharmaceuticals Development
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cour Pharmaceuticals Development team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Cour Pharmaceuticals Development was founded in 2012 by Daniel Getts.
DG
Daniel GettsFounder
JJ
John J. PuisisExecutiveJohn Puisis is an executive with over 25 years in life sciences and biotechnology. He co-founded Cour Pharmaceuticals and previously served as CEO of Tolera Therapeutics and Third Wave Technologies (NASDAQ: TWTI), and holds an MBA from Kellogg School of Management and a BS in Accounting from Northern Illinois University.
Board
CM
Catherine MackeyBoard director
Reported raises · per SEC filings
Form D private placements$669.3K disclosed across 2 rounds · 2014–2015
▶$169.3KraisedJan 2016 · 2 investors · BiotechnologyRule 506(b)
▶$169.3KraisedJan 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John J. PuisisExecutive Officer, Director
- James HerrmannExecutive Officer, Director
- Catherine MackeyDirector
- Offering amount
- $169.3K
- Amount sold
- $169.3K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedAug 2014 · 1 investors · Biotechnology
▶$500KraisedAug 2014 · 1 investors · Biotechnology
Officers, directors & promoters on the filing
- Daniel GettsDirector
- John PuisisExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Cour Pharmaceuticals Development?
- Cour Pharmaceuticals Development was founded by Daniel Getts in 2012.
- How much funding has Cour Pharmaceuticals Development raised?
- Cour Pharmaceuticals Development has disclosed $669.3K raised across 2 rounds.
- Where is Cour Pharmaceuticals Development headquartered?
- Cour Pharmaceuticals Development is headquartered in Northbrook, US.